Filed: 8/14/2025ACC: 0001931118-25-000006
📋 What this filing means
SUPERSTRING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $84.46M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$84.46M
Total AUM (reported)
8.36M
Total Shares
Allocation by class
COM$61.32M72.6%
SPONSORED ADS$6.75M8.0%
ADR$4.72M5.6%
SHS USD$4.68M5.5%
COM NEW$3.11M3.7%
COM PAR $.01$1.47M1.7%
COM STK$1.09M1.3%
Portfolio Concentration
Top 3$20.45M24.2%
4–10$32.31M38.3%
11–25$27.44M32.5%
Rest$4.25M5.0%
Top 3 weight
24.2%
Top 10 weight
62.5%
Voting Authority Distribution
Total shares with voting rights: 8.36M
Sole
Full voting authority
8.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
SOLENO THERAPEUTICS INC
SOLEShares83.69K
TypeSH
Market value$7.01M
8.30%
Sole
83.69K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares962.95K
TypeSH
Market value$6.91M
8.19%
Sole
962.95K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares68.98K
TypeSH
Market value$6.52M
7.73%
Sole
68.98K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares40.61K
TypeSH
Market value$5.10M
6.04%
Sole
40.61K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares1.29M
TypeSH
Market value$4.80M
5.68%
Sole
1.29M
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares130.42K
TypeSH
Market value$4.74M
5.61%
Sole
130.42K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares134.90K
TypeSH
Market value$4.72M
5.59%
Sole
134.90K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares44.11K
TypeSH
Market value$4.68M
5.54%
Sole
44.11K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares96.77K
TypeSH
Market value$4.18M
4.95%
Sole
96.77K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares276.47K
TypeSH
Market value$4.09M
4.84%
Sole
276.47K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares98.27K
TypeSH
Market value$3.88M
4.60%
Sole
98.27K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares344.92K
TypeSH
Market value$3.50M
4.15%
Sole
344.92K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.12M
TypeSH
Market value$2.54M
3.01%
Sole
1.12M
Shared
0.00
None
0.00
89BIO INC
SOLEShares212.38K
TypeSH
Market value$2.09M
2.47%
Sole
212.38K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares61.10K
TypeSH
Market value$2.02M
2.39%
Sole
61.10K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares189.70K
TypeSH
Market value$1.76M
2.09%
Sole
189.70K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.06M
TypeSH
Market value$1.61M
1.91%
Sole
1.06M
Shared
0.00
None
0.00
TECTONIC THERAPEUTIC INC
SOLEShares79.06K
TypeSH
Market value$1.57M
1.86%
Sole
79.06K
Shared
0.00
None
0.00
INSMED INC
SOLEShares14.57K
TypeSH
Market value$1.47M
1.74%
Sole
14.57K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares4.87K
TypeSH
Market value$1.40M
1.66%
Sole
4.87K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares47.04K
TypeSH
Market value$1.34M
1.58%
Sole
47.04K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares87.91K
TypeSH
Market value$1.20M
1.43%
Sole
87.91K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares360K
TypeSH
Market value$1.09M
1.29%
Sole
360K
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares111.61K
TypeSH
Market value$1.08M
1.28%
Sole
111.61K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares71.07K
TypeSH
Market value$885.5K
1.05%
Sole
71.07K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS INCSOLE | COM | 83.69K | SH | $7.01M 8.30% | 83.69K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 962.95K | SH | $6.91M 8.19% | 962.95K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 68.98K | SH | $6.52M 7.73% | 68.98K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 40.61K | SH | $5.10M 6.04% | 40.61K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 1.29M | SH | $4.80M 5.68% | 1.29M | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 130.42K | SH | $4.74M 5.61% | 130.42K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 134.90K | SH | $4.72M 5.59% | 134.90K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 44.11K | SH | $4.68M 5.54% | 44.11K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 96.77K | SH | $4.18M 4.95% | 96.77K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 276.47K | SH | $4.09M 4.84% | 276.47K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 98.27K | SH | $3.88M 4.60% | 98.27K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 344.92K | SH | $3.50M 4.15% | 344.92K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.12M | SH | $2.54M 3.01% | 1.12M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 212.38K | SH | $2.09M 2.47% | 212.38K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 61.10K | SH | $2.02M 2.39% | 61.10K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 189.70K | SH | $1.76M 2.09% | 189.70K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.06M | SH | $1.61M 1.91% | 1.06M | 0.00 | 0.00 |
TECTONIC THERAPEUTIC INCSOLE | COM | 79.06K | SH | $1.57M 1.86% | 79.06K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 14.57K | SH | $1.47M 1.74% | 14.57K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 4.87K | SH | $1.40M 1.66% | 4.87K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 47.04K | SH | $1.34M 1.58% | 47.04K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 87.91K | SH | $1.20M 1.43% | 87.91K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 360K | SH | $1.09M 1.29% | 360K | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 111.61K | SH | $1.08M 1.28% | 111.61K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 71.07K | SH | $885.5K 1.05% | 71.07K | 0.00 | 0.00 |
Page 1 of 2